Myelography was performed on 78 @entity1 with @entity0 who had signs or symptoms compatible with @entity1745 . Of 42 @entity1 (54%) with extradural defects, 21 (50%) had a complete block. All @entity1 with positive myelograms (M+) had a positive bone scan and 41 of 42 (97%) had positive skeletal x-rays. Except for @entity451 , @entity1746 , or a sensory level abnormality, signs and symptoms were usually not precise enough to accurately predict @entity1 with @entity602 ; however, @entity615 , @entity809 , and @entity1494 were significantly more common in M+ @entity1 . @entity2841 protein was elevated in almost all M+ @entity1 but also in approximately half of the M- group. Cytology and @entity413 analysis of @entity2841 were not of value in predicting @entity602 . Response to treatment was better for @entity1 with fewer sites of @entity3 and a shorter time from diagnosis to treatment. There was no notable difference in survival between M+ and M- @entity1 . Myelography remains the most precise tool for diagnosing @entity602 . Unfortunately, the prognosis of @entity1 with metastatic @entity0 is poor regardless of whether @entity1745 is present.

@entity1745 in XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity0 :: ('MESH:D001943', 'Disease') :: ['breast cancer'] @entity1494 :: ('MESH:D001745', 'Disease') :: ['bladder or bowel dysfunction'] @entity809 :: ('MESH:D010292', 'Disease') :: ['paresthesias'] @entity602 :: ('MESH:D013118', 'Disease') :: ['cord lesions', 'cord involvement', 'spinal cord lesions'] @entity1746 :: ('MESH:D020335', 'Disease') :: ['paraparesis'] @entity615 :: ('MESH:D001416', 'Disease') :: ['back pain'] @entity1745 :: ('MESH:D013117', 'Disease') :: ['spinal cord compression'] @entity3 :: ('MESH:D009362', 'Disease') :: ['metastatic disease'] @entity451 :: ('MESH:C536857', 'Disease') :: ['paraplegia'] @entity2841 :: ('1437', 'Gene') :: ['CSF', 'Cerebrospinal fluid (CSF)'] @entity413 :: ('MESH:D005947', 'Chemical') :: ['glucose']
@entity0 :: (MESH:D001943,Disease) :: ['breast cancer']
